1. Home
  2. AUPH vs SCSC Comparison

AUPH vs SCSC Comparison

Compare AUPH & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • SCSC
  • Stock Information
  • Founded
  • AUPH 1993
  • SCSC 1992
  • Country
  • AUPH Canada
  • SCSC United States
  • Employees
  • AUPH N/A
  • SCSC N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • SCSC Retail: Computer Software & Peripheral Equipment
  • Sector
  • AUPH Health Care
  • SCSC Technology
  • Exchange
  • AUPH Nasdaq
  • SCSC Nasdaq
  • Market Cap
  • AUPH 1.1B
  • SCSC 1.1B
  • IPO Year
  • AUPH 1999
  • SCSC 1994
  • Fundamental
  • Price
  • AUPH $8.01
  • SCSC $40.99
  • Analyst Decision
  • AUPH Strong Buy
  • SCSC Hold
  • Analyst Count
  • AUPH 3
  • SCSC 1
  • Target Price
  • AUPH $10.33
  • SCSC N/A
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • SCSC 198.7K
  • Earning Date
  • AUPH 02-13-2025
  • SCSC 01-30-2025
  • Dividend Yield
  • AUPH N/A
  • SCSC N/A
  • EPS Growth
  • AUPH N/A
  • SCSC N/A
  • EPS
  • AUPH N/A
  • SCSC 2.54
  • Revenue
  • AUPH $220,361,000.00
  • SCSC $3,021,788,000.00
  • Revenue This Year
  • AUPH $36.97
  • SCSC $2.58
  • Revenue Next Year
  • AUPH $16.43
  • SCSC $4.90
  • P/E Ratio
  • AUPH N/A
  • SCSC $15.74
  • Revenue Growth
  • AUPH 38.72
  • SCSC N/A
  • 52 Week Low
  • AUPH $4.71
  • SCSC $31.01
  • 52 Week High
  • AUPH $10.67
  • SCSC $53.90
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 45.28
  • SCSC 21.54
  • Support Level
  • AUPH $7.67
  • SCSC $49.32
  • Resistance Level
  • AUPH $8.54
  • SCSC $50.76
  • Average True Range (ATR)
  • AUPH 0.27
  • SCSC 1.67
  • MACD
  • AUPH 0.03
  • SCSC -1.02
  • Stochastic Oscillator
  • AUPH 43.62
  • SCSC 2.37

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About SCSC ScanSource Inc.

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: